Basic Science

Three research scientists, including a nephrologist, awarded Nobel Prize in Medicine for work with how cells sense and adapt to oxygen

Announced on October 7th, the Nobel Prize in Medicine was jointly awarded to a trio of scientists, William G. Kaelin Jr., Peter J. Ratcliffe, and Gregg L. Semenza, for their work on “how cells sense and adapt to oxygen availability,” The New York Times reports.

These “investigators uncovered detailed genetic responses to changing oxygen levels that allow cells in the bodies of humans and other animals sense and respond to fluctuations, increasing and decreasing how much oxygen they receive.”

JASN Editor in Chief Josie Briggs, MD, Appointed Interim Executive Director of PCORI

On September 27th, the Patient-Centered Outcomes Research Institute (PCORI) announced the appointment of Josephine P. Briggs, MD, as PCORI’s Interim Executive Director, starting on November 1, 2019. Briggs will lead the organization during its search for a replacement for Joe Selby, MD, MPH, who announced plans to retire as Executive Director by year’s end. She will continue her work as JASN Editor-in-Chief during this time.

Interview with Dr. Michael Allon, editor-in-chief of Kidney360, on new ideas for the journal

allon-michael2_1.jpgKidney News Online (KNO) recently spoke with Michael Allon, MD, the inaugural Editor-in-Chief for the newest journal from the American Society of Nephrology, Kidney360. As the open access, online only journal began accepting manuscripts on October 1st, KNO wanted to learn more about the ideas behind the new journal.

 

Patients Continue to Urge the Senate Support KidneyX Appropriations in New Al.com Op-ed

Following a recent letter to the editor in the Kansas City Star, kidney patients continue to urge their congressional representatives to support KidneyX during the Senate appropriations process.

Joint ASPN/ASN Statement sent to the House Oversight Committee criticizing the ending of the deferred medical action policy for immigrants

On Monday September 2nd, the Trump Administration announced a change to a policy that allowed immigrants to receive a temporary reprieve from deportation while receiving life-savings medical care in the US.

Advancing Nephrology: Division Leaders Advise ASN

Asserting the value of nephrology

Physician productivity and compensation

Financial support of educational effort

Recruitment, retention, diversity and inclusion

Ensuring that Nephrology fellowship programs provide quality training in all aspects of kidney care

ASN launches new initiative aiming to save lives of people suffering with acute kidney injury

Made possible by a grant from Baxter Healthcare Corporation, the effort called AKI!Now: Promoting Excellence in the Prevention and Treatment of Acute Kidney Injury, will aim to help people suffering from acute kidney injury (AKI).

First US cell-therapy trial for kidney transplant patients launched at University of Wisconsin Health

“The UW Program for Advanced Cell Therapy (PACT) will use the personalized cell therapy treatment to study its effects on a viral infection faced by around 30-40% of kidney and/or pancreas transplant recipients.

Dr. Reshma Kewalramani named incoming president and CEO of Vertex Pharmaceuticals, former member ASN KHI Board of Directors

Announced July 25, Dr. Reshma Kewalramani will be promoted to president and CEO of Vertex Pharmaceuticals. She is currently the chief medical officer for the company and was previously a practicing nephrologist who earned her medical doctorate at Boston University and trained at Bigham & Women’s Hospital.

Dr. Kewalramani will be the first woman to run a large biotechnology firm. Vortex’s share price “rose 360% and its sales doubled to $3 billion annually” under the previous CEO, largely due the company’s pharmaceuticals used to treat cystic fibrosis.

In Case You Missed It: Exclusive ASN Webinar on Advancing American Kidney Health

On July 26, 2019, the ASN policy team hosted anexclusive webinar discussing the Advancing American Kidney Health initiative. Click to see the slides used during the presentation. EAGnfkXW4AQEvvp_0.jpg

Pages